Clinical Trial Results Show Active Chest Tube Clearance as Part of an ERAS Program Significantly Improves Outcomes in Cardiac Surgery
ClearFlow, Inc., a medical device company based in Irvine, California, announced positive results from a clinical trial published in the peer-reviewed journal Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. The study, conducted by cardiac surgeons at Franciscan Health Indianapolis, is detailed in the article, “Active Chest Tube Clearance Added to an Enhanced Recovery After Cardiac Surgery (ERAS) Program Improves Outcomes and Reduces Resource Utilization.”
